Level D· Scientific groundwork from lab and animal studiesLaboratory StudyPubMed

Anti-inflammatory effect of stromal vascular fraction cells in fat transplantation.

Zhu M., Xue J., Lu S., Yuan Y., Liao Y., Qiu J.

Laboratory Study on Chronic Inflammation, published in Exp Ther Med (2018) — summary generated from the PubMed abstract.

Open my reading list
Level D· Scientific groundwork from lab and animal studiesEvidence level of this study

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Laboratory Study
Journal
Exp Ther Med (2018)
Country
Greece
Reported sample size
—
Source database
PubMed
PMID
30680025
PMCID
PMC6327643
DOI
10.3892/etm.2018.7082
Citations
22

Abstract (original English)

In previous studies, it has been demonstrated that the stromal vascular fraction (SVF) promoted the retention rate of grafts following fat transplantation through its angiogenic properties. However, the effect of SVF on inflammatory response subsequent to fat transplantation remains unclear. Fat from C57 mice were mixed with green fluorescent protein (GFP) SVF cells or phosphate-buffered saline and transplanted into C57BL/6 mice. The graft was harvested and immunofluorescent staining was performed on 1, 7, 14 and 30 days. The numbers of vessels and macrophages, as well as the inflammation level, in the two groups were evaluated. Although the GFP fluorescence indicated that most SVF cells were dead following transplantation, there was a higher graft retention rate in the SVF-assisted group compared with the control group. The SVF-assisted group also presented higher expression levels of interleukin (IL)-6 and tumor necrosis factor-α, and lower levels of IL-10, as well as increased M2 macrophages in comparison with the control group. Therefore, the results indicated that SVF promoted the retention rate of grafts following fat transplantation through the well-known pro-angiogenic mechanism (paracrine function and involvement in the formation of new vessels), as well as through the anti-inflammatory property of SVF (expression and suppression of various cytokines and conversion of

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.
  • • This is preclinical work; animal or laboratory results cannot be applied to humans.

Evidence level

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

How we grade evidence

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research